CHERRY HILL, N.J., May 28 /PRNewswire-FirstCall/ -- Nuvilex, Inc. (OTC Bulletin Board: NVLX), an emerging healthcare consumer products company, announced today that Charleston Kentrist 41 Direct, Inc. (CK41), the Company's joint venture marketing partner for purEffect(TM), a four-step acne treatment system, has updated its product launch plans.
The previously announced mid-May 2009 launch has been pushed back to allow Mr. Savage, CK41's new Chief Executive Officer, to impart his experience and knowledge into the purEffect formulation, packaging design and marketing plan. Presently, five thousand (5,000) newly formulated and designed purEffect packages are in production. Additionally, the competitive landscape for over-the-counter acne treatment products has significantly changed requiring new thinking on how to effectively market and price purEffect. CK41 is revising its Internet marketing plans and is in the process of negotiating a new mass media promotion campaign, which will include either renegotiated existing or new celebrity endorsements. Assuming current plans stay on target, purEffect should be ready for market by the end of June 2009.
"Mr. Savage is a renowned expert in cosmetics brand development and marketing. We believe in his ability and have confidence he will launch purEffect the right way," stated Martin Schmieg, Chairman and CEO of Nuvilex, Inc. "purEffect is a viable product that can and will compete successfully in the $1 billion over-the-counter acne treatment market. The six-week delay from the planned mid-May launch is insignificant compared to the invaluable contributions that Mr. Savage is making to the product, its market launch and commercial success. Everything that is good is worth waiting for."
About purEffect
purEffect is a comprehensive, all-in-one acne treatment solution that is designed to cleanse, tone, and heal the skin. purEffect combines a un
'/>"/>
| SOURCE Nuvilex, Inc. Copyright©2009 PR Newswire. All rights reserved |